Tsi-klim - instructions for use, doses, side effects, contraindications

Similar drugsTo uncover

Dosage form: & nbspcoated tablets

Composition:

Active ingredient:

tsimitsifugi extract dry with the content of the sum of triterpenovyh glycosides in terms of 27-deoxyaktein 2.5% - 0.02 g.

Auxiliary components of the kernel:

cellulose microcrystalline - 0.145 g, potato starch - 0.055 g, calcium stearate - 0.0019 g, silicon, colloidal dioxide - 0.0011 g.

Auxiliary components of the shell:

hypromellose (E 464, hydroxypropylmethylcellulose) - 0.0035 g, titanium dioxide (E 171) 0.0015 g, polysorbate 80 (tween 80) 0.0010 g, macrogol 400 (E 1521, polyethylene glycol 400) 0.0007 g, iron dye oxide red - 0.0002 g, ferric oxide brown oxide (FERRONAT) 0.0001 g /

Description:Round tablets covered with a shell, biconvex form, from pink to pink with a brown tinge, specific odor.

Pharmacotherapeutic group:An antimalaymic agent of plant origin

ATX: & nbsp

Other drugs for use in gynecology

Pharmacodynamics:

CI-KLIM has an estrogen-like effect, shows sedative properties, has a positive therapeutic effect on the autonomic nervous system.

CI-CLIM reduces levels of FSH and LH, increases the level of estradiol, which leads to the elimination of early climacteric disorders (psychoemotional and vegetovascular disorders) and delayed climacteric disorders associated with a decreased level of estrogen.

The therapeutic effect of the drug CI-KLIM develops gradually and manifests itself after approximately 2-4 weeks of treatment.

Indications:Vegeto-vascular and psychoemotional disorders in premenopausal and postmenopausal ("hot flashes", excessive sweating, sleep disturbances, increased nervous excitability, mood changes, apathy, etc.). Disorders associated with a decrease in the level of estrogen during the menopause.

Contraindications:

Hypersensitivity to the components of the drug, estrogen - dependent tumors.

Carefully:Violation of the function of the liver, epilepsy, diseases and brain trauma (use is possible only after consulting a doctor).

Pregnancy and lactation:

The drug should not be used during pregnancy and lactation.

Dosing and Administration:CI-KLIM® take inside 1 tablet (not chewing, squeezed a small amount of liquid) 2 times a day, if possible, at the same time of day (morning and evening). The duration of treatment is determined by the doctor.

Side effects:Allergic reactions to the drug components are possible. In rare cases, there may be pain in the epigastric region and an increase in body weight.

Overdose:In case of accidental use of the drug in doses much higher than recommended, dyspepsia, gastralgia, and liver dysfunction may be observed. Treatment is symptomatic.

Interaction:In connection with the possibility of overdose it is not recommended to take with other preparations containing tsimitsifugi extract.

Special instructions:

Without consulting a doctor, the drug should not be taken for more than 3 months.

When changing the nature of the menstrual cycle, as well as with prolonged or other newly arising complaints, you should consult a doctor.

At the onset of pregnancy, it is necessary to stop taking the drug and consult a doctor.

Effect on the ability to drive transp. cf. and fur:The drug in recommended doses does not affect the ability to drive a car and work with machines.

Form release / dosage:The tablets covered with a cover of 20 mg.

Packaging:

For 30, 40, 60 or 90 tablets in a can of polymer. Each bank along with the instruction for use is placed in a pack of cardboard.

For 20 tablets in a contour mesh box made of polyvinylchloride film and aluminum foil.For 1, 2, 3 or 4 contour squares, together with the instruction for use, they are placed in a pack of cardboard.

Storage conditions:In a dry, the dark place at a temperature of no higher than 25 ° C. Keep out of the reach of children.

Shelf life:

2 years.

Do not use after the expiration date.

Terms of leave from pharmacies:Without recipe

Registration number:LSR-006592/09

Date of registration:18.08.2009

Expiration Date:Unlimited

The owner of the registration certificate:EVALAR, CJSC EVALAR, CJSC Russia

Manufacturer: & nbsp

EVALAR, CJSC Russia

Information update date: & nbsp28.01.2018

Illustrated instructions

Instructions

Tsi-klim® (Ci-klim®)